BTAI — BioXcel Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for BioXcel Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	233	194	65.2	29.9	28.4
Net Total Accounts Receivable
Net Total Receivables	—	0.248	0.071	0.131	0.233
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	237	203	72.1	37.4	44.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.54	2.06	1.47	0.857	0.231
Other Long Term Assets
Total Assets	239	206	73.7	38.3	44.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16.7	32.9	27.3	22.2	53.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.8	129	130	131	140
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	222	76.8	-56.5	-93.1	-95.5
Total Liabilities & Shareholders' Equity	239	206	73.7	38.3	44.9
Total Common Shares Outstanding